Microencapsulation of phenylpropanolamine to achieve sustained release

Area of Science:

• Pharmaceutical Sciences
• Materials Science

Background:

• Sustained release formulations are crucial for optimizing drug efficacy and patient compliance.
• Microencapsulation is a common technique for controlling drug release kinetics.

Purpose of the Study:

• To investigate methods for achieving an acceptable sustained release profile for phenylpropanolamine hydrochloride (PPA HCl) using microencapsulation.
• To evaluate the impact of particle size and formulation components on PPA HCl release.

Main Methods:

• Microencapsulation of PPA HCl using cellulose acetate butyrate.
• Modification of drug particle size prior to microencapsulation.
• Utilizing a drug-resin complex instead of drug powder for microencapsulation.
• Assessing drug release profiles in dissolution media with varying pH.

Main Results:

• Initial microcapsules with PPA HCl and cellulose acetate butyrate did not achieve sustained release.
• Reducing PPA HCl particle size decreased the drug release rate.
• Replacing PPA HCl powder with a PPA HCl-resin complex successfully yielded the desired sustained release profile.
• The pH of the dissolution media significantly affected the drug release characteristics.

Conclusions:

• The formulation of microcapsules for sustained release of PPA HCl is highly dependent on the physical form of the drug.
• Employing a drug-resin complex is an effective strategy for controlling PPA HCl release from microcapsules.
• Environmental factors like pH play a critical role in the performance of PPA HCl microcapsule formulations.